Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Genetic Moderators of the Impact of Physical Activity on Depressive Symptoms.

Dotson VM, Hsu FC, Langaee TY, McDonough CW, King AC, Cohen RA, Newman AB, Kritchevsky SB, Myers V, Manini TM, Pahor M; LIFE STUDY GROUP.

J Frailty Aging. 2016;5(1):6-14. doi: 10.14283/jfa.2016.76.

2.

Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress.

Rodrigues R, Smith MA, Wang X, Perry G, Lee HG, Zhu X, Petersen RB.

Future Neurol. 2012 May;7(3):287-305.

3.

Mirtazapine versus other antidepressive agents for depression.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawa TA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528. doi: 10.1002/14651858.CD006528.pub2. Review.

4.

Resolving the relationship between ApolipoproteinE and depression.

Slifer MA, Martin ER, Gilbert JR, Haines JL, Pericak-Vance MA.

Neurosci Lett. 2009 May 15;455(2):116-9. doi: 10.1016/j.neulet.2009.03.007. Epub 2009 Mar 6.

5.

Pharmacogenomic strategy for individualizing antidepressant therapy.

Lin KM, Perlis RH, Wan YJ.

Dialogues Clin Neurosci. 2008;10(4):401-8. Review.

6.

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Lotrich FE, Pollock BG.

Neuropsychiatr Dis Treat. 2005 Mar;1(1):17-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk